CTABF

Canntab Therapeutics Limited

USD

Set alert

Price alert · CTABF

All alert types
0.00 USD 0.00 0.00%
As of Nov 28, 2025
0.0001 Day range 0.0073
0.0001 52-week range 0.0073
Open
0.0073
Prev close
0.0001
Mkt cap
3.89K
Vol
2.00K
Avg vol
1.03K
EPS
-0.06
P/E
-0.00
More statistics
Low
0.0001
High
0.0073

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CTABF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-39.49 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.6×
FY 2013: -0.8×FY 2014: -4.5×FY 2015: -6.3×FY 2016: -11.9×FY 2017: -117×FY 2018: -5.4×FY 2019: -7.6×FY 2020: -11.4×FY 2021: -7.7×FY 2022: -2.6×
FY 2013 5y median -7.6× FY 2022
P/S 32.5×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 474×FY 2019: 77.6×FY 2020: 224×FY 2021: 0.0×FY 2022: 32.5×
FY 2013 5y median 77.6× FY 2022
P/B -30.7×
FY 2013: 10.0×FY 2014: 6.3×FY 2015: 28.9×FY 2016: 2.2×FY 2017: 126×FY 2018: 2.9×FY 2019: 8.2×FY 2020: 8.5×FY 2021: 15.2×FY 2022: -30.7×
FY 2013 5y median 8.2× FY 2022
P/FCF -3.3×
FY 2013: -0.9×FY 2014: -2.6×FY 2015: -37.6×FY 2016: -8.0×FY 2017: -287×FY 2018: -8.6×FY 2019: -7.0×FY 2020: -10.6×FY 2021: -10.8×FY 2022: -3.3×
FY 2013 5y median -8.6× FY 2022
EV/EBITDA -4.3×
FY 2013: -0.8×FY 2014: -2.0×FY 2015: -6.2×FY 2016: 11.2×FY 2017: -116×FY 2018: -3.6×FY 2019: -7.5×FY 2020: -12.5×FY 2021: -11.4×FY 2022: -4.3×
FY 2013 5y median -7.5× FY 2022
EV/Sales 36.4×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 316×FY 2019: 75.9×FY 2020: 214×FY 2021: 0.0×FY 2022: 36.4×
FY 2013 5y median 75.9× FY 2022
FCF Yield -30.7%
FY 2013: -109.1%FY 2014: -38.7%FY 2015: -2.7%FY 2016: -12.6%FY 2017: -0.3%FY 2018: -11.6%FY 2019: -14.2%FY 2020: -9.4%FY 2021: -9.2%FY 2022: -30.7%
FY 2013 5y median -11.6% FY 2022

Profitability

Gross Margin -320.1%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: 59.8%FY 2020: 100.0%FY 2021: 0.0%FY 2022: -320.1%
FY 2013 5y median 59.8% FY 2022
Operating Margin -1419.4%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -9087.7%FY 2019: -1042.4%FY 2020: -1961.8%FY 2021: 0.0%FY 2022: -1419.4%
FY 2013 5y median -1419.4% FY 2022
Net Margin -1257.6%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -9031.4%FY 2019: -1024.4%FY 2020: -1955.4%FY 2021: 0.0%FY 2022: -1257.6%
FY 2013 5y median -1257.6% FY 2022
ROE 1185.4%
FY 2013: -1292.1%FY 2014: -140.1%FY 2015: -455.7%FY 2016: -18.5%FY 2017: -107.5%FY 2018: -56.0%FY 2019: -108.4%FY 2020: -73.9%FY 2021: -194.8%FY 2022: 1185.4%
FY 2013 5y median -73.9% FY 2022
ROIC -230.4%
FY 2013: -1292.1%FY 2014: -296.5%FY 2015: -456.3%FY 2016: 18.5%FY 2017: -107.5%FY 2018: -54.6%FY 2019: -106.0%FY 2020: -60.9%FY 2021: -71.2%FY 2022: -230.4%
FY 2013 5y median -71.2% FY 2022
ROA -129.3%
FY 2013: -777.5%FY 2014: -88.1%FY 2015: -63.3%FY 2016: -12.9%FY 2017: -98.2%FY 2018: -50.7%FY 2019: -94.8%FY 2020: -47.3%FY 2021: -69.5%FY 2022: -129.3%
FY 2013 5y median -69.5% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2013: -100.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 800.0%FY 2020: -44.4%FY 2021: -100.0%FY 2022: 0.0%
FY 2013 FY 2022
Operating Income -18.3%
FY 2013: -7.3%FY 2014: 59.1%FY 2015: 72.0%FY 2016: 197.2%FY 2017: -742.3%FY 2018: -117.0%FY 2019: -3.2%FY 2020: -4.6%FY 2021: -34.6%FY 2022: -18.3%
FY 2013 FY 2022
EPS (diluted) 24.8%
FY 2013: 11.5%FY 2014: 81.6%FY 2015: 22.9%FY 2016: 36.4%FY 2017: 90.1%FY 2018: -47.8%FY 2019: 11.6%FY 2020: 1.2%FY 2021: -35.4%FY 2022: 24.8%
FY 2013 FY 2022
Free Cash Flow 8.2%
FY 2013: -22.0%FY 2014: 60.3%FY 2015: 94.2%FY 2016: -754.3%FY 2017: -76.5%FY 2018: -223.0%FY 2019: -80.6%FY 2020: -5.8%FY 2021: -13.9%FY 2022: 8.2%
FY 2013 FY 2022

Financial Health

Current Ratio 0.6×
FY 2013: 2.5×FY 2014: 0.7×FY 2015: 0.1×FY 2016: 3.3×FY 2017: 10.1×FY 2018: 14.2×FY 2019: 8.2×FY 2020: 2.5×FY 2021: 2.1×FY 2022: 0.6×
FY 2013 5y median 2.5× FY 2022
Quick Ratio 0.4×
FY 2013: 2.5×FY 2014: 0.7×FY 2015: 0.1×FY 2016: 3.3×FY 2017: 10.1×FY 2018: 14.2×FY 2019: 8.2×FY 2020: 1.8×FY 2021: 1.1×FY 2022: 0.4×
FY 2013 5y median 1.8× FY 2022
Debt / Equity -5.9×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.7×FY 2022: -5.9×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA -0.5×
FY 2013: 0.1×FY 2014: 0.1×FY 2015: 0.1×FY 2016: -0.6×FY 2017: 0.9×FY 2018: 1.8×FY 2019: 0.2×FY 2020: 0.6×FY 2021: -0.0×FY 2022: -0.5×
FY 2013 5y median 0.2× FY 2022
Interest Coverage -7.3×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -98.4×FY 2021: -18.6×FY 2022: -7.3×
FY 2013 5y median -7.3× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-05-31